Literature DB >> 22239468

Transplanted bone marrow stromal cells protect neurovascular units and ameliorate brain damage in stroke-prone spontaneously hypertensive rats.

Masaki Ito1, Satoshi Kuroda, Taku Sugiyama, Katsuhiko Maruichi, Masahito Kawabori, Naoki Nakayama, Kiyohiro Houkin, Yoshinobu Iwasaki.   

Abstract

This study was aimed to assess whether bone marrow stromal cells (BMSC) could ameliorate brain damage when transplanted into the brain of stroke-prone spontaneously hypertensive rats (SHR-SP). The BMSC or vehicle was stereotactically engrafted into the striatum of male SHR-SP at 8 weeks of age. Daily loading with 0.5% NaCl-containing water was started from 9 weeks. MRIs and histological analysis were performed at 11 and 12 weeks, respectively. Wistar-Kyoto rats were employed as the control. As a result, T2-weighted images demonstrated neither cerebral infarct nor intracerebral hemorrhage, but identified abnormal dilatation of the lateral ventricles in SHR-SP. HE staining demonstrated selective neuronal injury in their neocortices. Double fluorescence immunohistochemistry revealed that they had a decreased density of the collagen IV-positive microvessels and a decreased number of the microvessels with normal integrity between basement membrane and astrocyte end-feet. BMSC transplantation significantly ameliorated the ventricular dilatation and the breakdown of neurovascular integrity. These findings strongly suggest that long-lasting hypertension may primarily damage neurovascular integrity and neurons, leading to tissue atrophy and ventricular dilatation prior to the occurrence of cerebral stroke. The BMSC may ameliorate these damaging processes when directly transplanted into the brain, opening the possibility of prophylactic medicine to prevent microvascular and parenchymal-damaging processes in hypertensive patients at higher risk for cerebral stroke.
© 2012 Japanese Society of Neuropathology.

Entities:  

Mesh:

Year:  2012        PMID: 22239468     DOI: 10.1111/j.1440-1789.2011.01291.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  8 in total

Review 1.  Update on therapeutic mechanism for bone marrow stromal cells in ischemic stroke.

Authors:  Huan Wan; Fangqin Li; Lei Zhu; Jing Wang; Zizhen Yang; Yujun Pan
Journal:  J Mol Neurosci       Date:  2013-09-19       Impact factor: 3.444

2.  Evaluating the efficacy of different types of stem cells in preserving gut barrier function in necrotizing enterocolitis.

Authors:  Christopher J McCulloh; Jacob K Olson; Yijie Wang; Jennifer Vu; Sarah Gartner; Gail E Besner
Journal:  J Surg Res       Date:  2017-03-31       Impact factor: 2.192

3.  Stem cells and necrotizing enterocolitis: A direct comparison of the efficacy of multiple types of stem cells.

Authors:  Christopher J McCulloh; Jacob K Olson; Yu Zhou; Yijie Wang; Gail E Besner
Journal:  J Pediatr Surg       Date:  2017-03-18       Impact factor: 2.545

4.  Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke.

Authors:  Masahito Kawabori; Rachid Kacimi; Tiina Kauppinen; Cyrus Calosing; Jong Youl Kim; Christine L Hsieh; Mary C Nakamura; Midori A Yenari
Journal:  J Neurosci       Date:  2015-02-25       Impact factor: 6.167

5.  Bone marrow mesenchymal stem cells ameliorate neurological deficits and blood-brain barrier dysfunction after intracerebral hemorrhage in spontaneously hypertensive rats.

Authors:  Chunyan Wang; Yiping Fei; Congshu Xu; Yue Zhao; Yujun Pan
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 6.  Current Opinion of Bone Marrow Stromal Cell Transplantation for Ischemic Stroke.

Authors:  Satoshi Kuroda
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-03-15       Impact factor: 1.742

Review 7.  Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke.

Authors:  Masahito Kawabori; Hideo Shichinohe; Satoshi Kuroda; Kiyohiro Houkin
Journal:  Int J Mol Sci       Date:  2020-10-06       Impact factor: 5.923

8.  Mesenchymal Stem Cell Sheet Promotes Functional Recovery and Palliates Neuropathic Pain in a Subacute Spinal Cord Injury Model.

Authors:  Kazuyoshi Yamazaki; Masahito Kawabori; Toshitaka Seki; Soichiro Takamiya; Kotaro Konno; Masahiko Watanabe; Kiyohiro Houkin; Miki Fujimura
Journal:  Stem Cells Int       Date:  2021-07-09       Impact factor: 5.443

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.